Altering the Human Genome: Mapping the Genome Editing Regulatory System in South Africa

Authors

DOI:

https://doi.org/10.17159/1727-3781/2021/v24i0a9179

Keywords:

CRISPR-Cas9, genome editing technology, policy-making, National Health Act 61 of 2003, South Africa

Abstract

Novel therapeutic strategies using genome editing technologies, such as CRISPR-Cas9, are revolutionising the way in which diseases can be prevented and treated in the future. Consequently, a global debate has emerged around the ethical and legal implications relating to the use of such technology in research, therapy, and human reproduction. This has brought to the forefront questions regarding the extent to which current policies respond to these issues. In this paper, we provide a “map” of South African policy relating to genome editing, and illustrate how current ethical guidelines and law regulate its use. We find that the South African policy framework is marred with inconsistencies and incompleteness, and that an opportunity exists for the normative and regulatory framework governing this field of research and therapeutic application in South Africa, to be reviewed and reformed. In this paper we present certain recommendations – with the goal of informing and supporting health policy and decision-making regarding the regulation of genome editing in South Africa. We suggest that by adopting a pragmatic regulatory approach, such recommendations serve to address public concern, reflect appropriate international perspectives, and provide a firm foundation for the development of genome editing regulation in South Africa.

GS82.png

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biography

Bonginkosi Shozi , University of KwaZulu-Natal

LLB LLM (UKZN).

Doctoral Fellow, School of Law, Howard College, University of KwaZulu-Natal

References

Bibliography

Literature

Araki M and Ishii T "International Regulatory Landscape and Integration of Corrective Genome Editing into in vitro Fertilization" 2014 Reprod Biol Endocrinol 1-12

Ashley E "Towards Precision Medicine" 2016 Nat Rev Genet 507-522

Baltimore D et al "A Prudent Path Forward for Genomic Engineering and Germ Line Gene Modification" 2015 Science 36-38

Baumann M "CRISPR/Cas9 Genome Editing – New and Old Ethical Issues Arising from a Revolutionary Technology" 2016 Nano Ethics 139-159

Blasimme A and Vayena E "'Tailored-to-you': Public Engagement and the Political Legitimation of Precision Medicine" 2016 Perspect Biol Med 172-188

Burgess M et al "Biobanking in British Columbia: Discussions of the Future of Personalized Medicine through Deliberative Public Engagement" 2008 Pers Med 285

Caplan AL et al "No Time to Waste: The Ethical Challenges Created by CRISPR" 2015 Sci Soc 1421-1426

Carroll D "Genome Engineering with Targetable Nucleases" 2014 Annu Rev Biochem 409-439

Cavaliere G "A 14-day Limit for Bioethics: The Debate over Human Embryo Research" 2017 BMC Medical Ethics 38

Cavaliere G et al "Regulating Genome Editing: For an Enlightened Democratic Governance" 2019 Cam Q Healthc Ethics 76-88

Chambers S "Deliberative Democratic Theory" 2003 Annu Rev Polit Sci 307-326

Cong L et al "Multiplex Genome Engineering Using CRISPR/Cas Systems" 2013 Science 819-823

Cribbs AP and Perera S "Science and Bioethics of CRISPR-Cas9 Gene Editing: An Analysis towards Separating Facts and Fiction" 2017 YJBM 625-634

Department of Health Ethics in Health Research: Principles, Structures and Processes 2nd ed (Department of Health Pretoria 2015)

Doudna JA and Charpentier E "The New Frontier of Genome Engineering with CRISPR-Cas9" 2014 Science 1077

Evans JP et al "Deflating the Genomic Bubble" 2011 Science 861-862

Feeney O et al "Patenting Foundational Technologies: Lessons from CRISPR and Other Core Biotechnologies" 2018 AJOB 36-48

Gupta RM and Musunuru K "Expanding the Genetic Editing Tool Kit: ZFNs, TALENs, and CRISPR-Cas9" 2014 J Clin Invest 4154-4161

Hopkins PD "Bad Copies: How Popular Media Represent Cloning as an Ethical Problem" 1998 Hastings Centre Report 6-13

Hsu PD et al "Development and Applications of CRISPR-Cas9 for Genome Engineering" 2014 Cell 1262-1278

Hwang WY et al "Efficient Genome Editing in Zebrafish Using a CRISPR-Cas9 System" 2013 Nat Biotechnol 227-229

Ishi T "Somatic Genome Editing for Health: Disease Treatments and Beyond" 2016 Curr Stem Cell Rep 313-320

Jinek M et al "RNA-programmed Genome Editing in Human Cells" 2013 eLife https://doi.org/10.7554/eLife.00471.001 accessed 8 February 2021

Jordaan D "Regulatory Crackdown on Stem Cell Therapy: What would the Position be in South Africa?" 2012 SAMJ 226-228

Lander ES "Brave New Genome" 2015 NEJM 5-8

Lander ES "The Heroes of CRSIPR" 2016 Cell 18-28

Lander ES et al "Adopt a Moratorium on Heritable Genome Editing" 2019 Nature 165-168

Liu JJ et al "CasX Enzymes Comprise a Distinct Family of RNA-guided Genome Editors" 2019 Nature 218-223

Mali P et al "RNA-guided Human Genome Engineering via Cas9" 2013 Science 823-826

National Academy of Sciences, Engineering, and Medicine Heritable Human Genome Editing (National Academies Press Washington 2020)

National Academies of Sciences, Engineering, and Medicine. Human Genome Editing: Science, Ethics, and Governance (National Academies Press Washington 2017)

National Academies of Sciences, Engineering, and Medicine Second International Summit on Human Genome Editing at the University of Hong Kong (National Academies Press Washington 2019)

Nature Medicine "Germ line Editing: Time for Discussion" 2015 Nat Med 295

Pillay S and Thaldar D "CRISPR: Challenges to South African Biotechnology Law" 2018 SAJBL 89-92

Posner S et al "Policy Impact of Ecosystem Services Knowledge" 2016 PNAS 1760-1765

Reardon S "Welcome to the CRISPR Zoo" 2016 Nature 160-163

Sanchez-Rivera FJ and Jacks T "Applications of the CRISPR-Cas9 System in Cancer Biology" 2015 Nat Rev Cancer 387-395

Steiner HJ "Political Participation as a Human Right" 1988 Harv Hum Rts YB 77-134

Townsend BA "Human Genome Editing: How to Prevent Rogue Actors" 2020 BMC Medical Ethics https://doi.org/10.1186/s12910-020-00527-w accessed 8 February 2021

Van den Belt H "Biotechnology, the US-EU Dispute and the Precautionary Principle" in Wesseler JHH (ed) Environmental Costs and Benefits of Transgenic Crops (Springer Dordrecht 2005) 185-197

Warnock M Report of the Committee of Inquiry into Human Fertilisation and Embryology (Her Majesty's Stationery Office London 1984)

Warnock M "Moral Thinking and Government Policy: The Warnock Committee on Human Embryology" 1985 Milbank Mem Fund Q 504-522

Wolinetz CD and Collins FS "NIH Supports Call for Moratorium on Clinical Uses of Germline Gene Editing" 2019 Nature 175

Case law

Bato Star Fishing (Pty) Ltd v Minister of Environmental Affairs and Tourism 2004 4 SA 490 (CC)

Cloete v S 2019 5 BCLR 544 (CC)

Cool ldeas I 186 CC v Hubbard 2014 4 SA 474 (CC)

Furman v State of Georgia 408 US 238 (1972)

Natal Joint Municipal Pension Fund v Endumeni Municipality 2012 4 SA 593 (SCA)

Public Servants Association obo Ubogu v Head, Department of Health, Gauteng 2018 2 SA 365 (CC)

Rossouw v Sachs 1964 2 SA 551 (A)

S v Makwanyane 1995 3 SA 391 (CC)

Legislation

Assisted Human Reproduction Act, 2004 (Canada)

Children's Act 38 of 2005

Consumer Protection Act 68 of 2008

Medicines and Related Substances Control Act 101 of 1965

National Health Act 61 of 2003

Protection of Personal Information Act 4 of 2013

Patents Act 57 of 1978

International instruments

United Nations Declaration on Human Cloning (2005)

Government publications

GN R175 in GG 35099 of 2 March 2012

GN R177 in GG 35099 of 2 March 2012

GN R178 in GG 35099 of 2 March 2012

GN R179 in GG 35099 of 2 March 2012

GN R180 in GG 35099 of 2 March 2012

GN R181 in GG 35099 of 2 March 2012

GN R182 in GG 35099 of 2 March 2012

GN R183 in GG 35099 of 2 March 2012

Internet sources

Centre for Genetics and Society 2018 Summary of Public Opinion Polls https://www.geneticsandsociety.org/internal-content/cgs-summary-public-opinion-polls#igmdata accessed 25 August 2019

HPCSA 2008 https://www.sada.co.za/media/documents/HPCSA_

Booklet_14_Biotechnology_Research_in_SA.pdf

Health Professions Council South Africa 2008 Booklet 14: General Ethical Guidelines for Biotechnology Research in South Africa - Guidelines for Good Practice in the Health Care https://www.sada.co.za/media/

documents/HPCSA_Booklet_14_Biotechnology_Research_in_SA.pdf accessed 2 April 2019

MRC 2001 http://www.mrc.ac.za/sites/default/files/attachments/2016-06-29/ethicsbook2.pdf

Medical Research Council 2001 Guidelines on Ethics for Medical Research: Reproductive Biology and Genetic Research (Book 2) http://www.mrc.ac.za/sites/default/files/attachments/2016-06-29/ethicsbook2.pdf accessed 8 February 2021

United Nations 2005 General Assembly Adopts United Nations Declaration on Human Cloning by Vote of 84-34-37 https://www.un.org/press/en/2005/

ga10333.doc.htm accessed 8 February 2021

World Health Organisation Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome 2020 Editing Human Genome Editing: A Draft Framework for Governance https://www.who.int/docs/default-source/ethics/governance-framework-for-human-genome-editing-2ndonlineconsult.pdf?ua=1 accessed 8 February 2021

Yong ED 2018 A Reckless and Needless Use of Gene Editing on Human Embryos https://www.theatlantic.com/science/archive/2018/11/first‐gene‐edited‐babies‐have‐allegedly‐been‐born‐in‐china/576661 accessed 2 April 2019

Published

2021-03-29

How to Cite

Townsend, B., & Shozi , B. . (2021). Altering the Human Genome: Mapping the Genome Editing Regulatory System in South Africa. Potchefstroom Electronic Law Journal, 24, 1–28. https://doi.org/10.17159/1727-3781/2021/v24i0a9179

Issue

Section

Articles